大肠直肠肝转移的分子途径和向治疗:从长椅到床边
Feng Liu1, Yue-Chen Zhao2, Yan Jiao3
1Department of Oncology, Tonghua Central Hospital, Tonghua, 134001, Jilin, China.
概括
结直肠肝转移 (CRLM) 涉及关键的分子通路,如Wnt/β-catenin,EGFR和血管生成. 了解这些途径有助于针对性治疗以改善结直肠癌患者的治疗结果.
科学领域:
- 癌症学
- 分子生物学
- 癌症转移
背景情况:
- 结直肠肝转移 (CRLM) 显著影响结直肠癌 (CRC) 的预后和生存率.
- 由于导致瘤进展的复杂分子机制,对CRLM的治疗是复杂的.
研究的目的:
- 分析涉及CRLM发展和进展的分子途径.
- 审查CRLM治疗中的当前向治疗方法和挑战.
- 探索个性化医疗在CRLM管理中的潜力.
主要方法:
- 在CRLM中详细分析Wnt/β-catenin信号传递,表皮生长因子受体 (EGFR) 和血管生成途径.
- 检查针对性治疗的临床前和临床数据,包括途径抑制剂和抗血管原剂.
- 讨论耐药性机制和组合治疗策略.
主要成果:
- 在CRLM中确定了Wnt/β-catenin,EGFR和血管生成的关键途径.
- 突出了针对性治疗的进展,如Wnt途径抑制剂,EGFR抑制剂和抗血管治疗.
- 已知的挑战包括治疗耐药性和组合方法的需要.
结论:
- 针对特定的分子途径为CRLM提供了有前途的治疗策略.
- 基于分子分析的个性化方法可以优化治疗选择并改善患者的结果.
- 进一步研究耐药性机制和组合疗法对于推进CRLM管理至关重要.
更多相关视频
11:43Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
12.8K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.9K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
